23/57
2.0 / 5 stars
All 57 Win/Lose results and 63 gray no-data contests shown below
TEVA Roast Me summary
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
- 2026-Q2: Total return Lose; Revenue growth No data; EPS growth No data.
- 2026-Q1: Total return Win; Revenue growth No data; EPS growth No data.
- 2025-Q4: Total return Win; Revenue growth No data; EPS growth No data.
- 2025-Q3: Total return Win; Revenue growth No data; EPS growth No data.
Trailing 1 year (4 quarters): 3 wins, 1 losses, 8 no dataLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/1 |
LoseTEVA / S&P 12.48% / 15.20% |
No dataTEVA / S&P / 15.00% |
No dataTEVA / S&P / 50.40% |
| 2026-Q11/1 |
WinTEVA / S&P -3.49% / -4.33% |
No dataTEVA / S&P / 11.30% |
No dataTEVA / S&P / 27.70% |
| 2025-Q41/1 |
WinTEVA / S&P 54.50% / 2.65% |
No dataTEVA / S&P / 9.00% |
No dataTEVA / S&P / 13.40% |
| 2025-Q31/1 |
WinTEVA / S&P 20.53% / 8.12% |
No dataTEVA / S&P / 4.61% |
No dataTEVA / S&P / 13.45% |
| 2025-Q20/1 |
LoseTEVA / S&P 9.04% / 10.94% |
No dataTEVA / S&P / 4.83% |
No dataTEVA / S&P / 10.63% |
| 2025-Q10/1 |
LoseTEVA / S&P -30.26% / -4.27% |
No dataTEVA / S&P / 4.98% |
No dataTEVA / S&P / 10.57% |
| 2024-Q41/1 |
WinTEVA / S&P 22.31% / 2.41% |
No dataTEVA / S&P / 5.25% |
No dataTEVA / S&P / 6.15% |
| 2024-Q31/1 |
WinTEVA / S&P 10.89% / 5.89% |
No dataTEVA / S&P / 5.89% |
No dataTEVA / S&P / 6.11% |
| 2024-Q21/1 |
WinTEVA / S&P 15.17% / 4.28% |
No dataTEVA / S&P / 5.38% |
No dataTEVA / S&P / 5.12% |
| 2024-Q11/1 |
WinTEVA / S&P 35.15% / 10.56% |
No dataTEVA / S&P / 5.71% |
No dataTEVA / S&P / 5.59% |
| 2023-Q40/1 |
LoseTEVA / S&P 2.35% / 11.69% |
No dataTEVA / S&P / 6.81% |
No dataTEVA / S&P / 7.78% |
| 2023-Q31/1 |
WinTEVA / S&P 35.46% / -3.27% |
No dataTEVA / S&P / 7.52% |
No dataTEVA / S&P / -5.03% |
| 2023-Q20/1 |
LoseTEVA / S&P -14.92% / 8.74% |
No dataTEVA / S&P / 9.50% |
No dataTEVA / S&P / -8.57% |
| 2023-Q10/1 |
LoseTEVA / S&P -2.96% / 7.50% |
No dataTEVA / S&P / 10.77% |
No dataTEVA / S&P / -15.69% |
| 2022-Q41/2 |
WinTEVA / S&P 13.01% / 7.56% |
No dataTEVA / S&P / 11.88% |
LoseTEVA / S&P -678.95% / -17.99% |
| 2022-Q31/2 |
WinTEVA / S&P 7.31% / -4.88% |
No dataTEVA / S&P / 13.47% |
LoseTEVA / S&P -275.76% / -1.41% |
| 2022-Q20/1 |
LoseTEVA / S&P -19.91% / -16.10% |
No dataTEVA / S&P / 13.71% |
No dataTEVA / S&P / 11.04% |
| 2022-Q11/1 |
WinTEVA / S&P 17.23% / -4.60% |
No dataTEVA / S&P / 15.97% |
No dataTEVA / S&P / 42.23% |
| 2021-Q40/1 |
LoseTEVA / S&P -17.76% / 11.03% |
No dataTEVA / S&P / 15.00% |
No dataTEVA / S&P / 96.40% |
| 2021-Q30/1 |
LoseTEVA / S&P -1.62% / 0.58% |
No dataTEVA / S&P / 10.77% |
No dataTEVA / S&P / 69.42% |
| 2021-Q20/2 |
LoseTEVA / S&P -14.21% / 8.55% |
No dataTEVA / S&P / 6.58% |
LoseTEVA / S&P -35800.00% / 51.81% |
| 2021-Q11/1 |
WinTEVA / S&P 19.59% / 6.17% |
No dataTEVA / S&P / -1.06% |
No dataTEVA / S&P / 7.39% |
| 2020-Q40/1 |
LoseTEVA / S&P 7.10% / 12.15% |
No dataTEVA / S&P / -3.72% |
No dataTEVA / S&P / -33.42% |
| 2020-Q30/1 |
LoseTEVA / S&P -26.93% / 8.93% |
No dataTEVA / S&P / -2.04% |
No dataTEVA / S&P / -27.10% |
| 2020-Q21/1 |
WinTEVA / S&P 37.31% / 20.54% |
No dataTEVA / S&P / -0.46% |
No dataTEVA / S&P / -27.11% |
| 2020-Q11/1 |
WinTEVA / S&P -8.37% / -19.60% |
No dataTEVA / S&P / 3.47% |
No dataTEVA / S&P / -14.75% |
| 2019-Q41/1 |
WinTEVA / S&P 42.44% / 9.07% |
No dataTEVA / S&P / 5.36% |
No dataTEVA / S&P / 2.99% |
| 2019-Q30/1 |
LoseTEVA / S&P -25.46% / 1.70% |
No dataTEVA / S&P / 5.02% |
No dataTEVA / S&P / 0.21% |
| 2019-Q20/1 |
LoseTEVA / S&P -41.14% / 4.30% |
No dataTEVA / S&P / 6.64% |
No dataTEVA / S&P / 8.65% |
| 2019-Q10/1 |
LoseTEVA / S&P 1.69% / 13.65% |
No dataTEVA / S&P / 8.12% |
No dataTEVA / S&P / 14.29% |
| 2018-Q40/1 |
LoseTEVA / S&P -28.41% / -13.52% |
No dataTEVA / S&P / 9.05% |
No dataTEVA / S&P / 18.23% |
| 2018-Q30/1 |
LoseTEVA / S&P -11.43% / 7.71% |
No dataTEVA / S&P / 10.21% |
No dataTEVA / S&P / 19.06% |
| 2018-Q21/1 |
WinTEVA / S&P 42.31% / 3.43% |
No dataTEVA / S&P / 9.03% |
No dataTEVA / S&P / 14.46% |
| 2018-Q10/3 |
LoseTEVA / S&P -9.82% / -0.76% |
LoseTEVA / S&P -4.06% / 7.68% |
LoseTEVA / S&P -79100.00% / 12.46% |
| 2017-Q41/3 |
WinTEVA / S&P 8.34% / 6.64% |
LoseTEVA / S&P 2.20% / 7.03% |
LoseTEVA / S&P -23328.57% / 13.82% |
| 2017-Q31/3 |
LoseTEVA / S&P -46.74% / 4.48% |
WinTEVA / S&P 15.50% / 5.68% |
LoseTEVA / S&P -443.93% / 17.57% |
| 2017-Q22/3 |
WinTEVA / S&P 4.80% / 3.09% |
WinTEVA / S&P 19.63% / 4.83% |
LoseTEVA / S&P -508.00% / 17.74% |
| 2017-Q11/3 |
LoseTEVA / S&P -10.63% / 6.07% |
WinTEVA / S&P 16.75% / 3.67% |
LoseTEVA / S&P -98.96% / 13.32% |
| 2016-Q41/3 |
LoseTEVA / S&P -20.50% / 3.82% |
WinTEVA / S&P 11.45% / 2.09% |
LoseTEVA / S&P -96.15% / 7.05% |
| 2016-Q31/3 |
LoseTEVA / S&P -7.81% / 3.85% |
WinTEVA / S&P 1.77% / 0.20% |
LoseTEVA / S&P -16.43% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | TEVA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 98.36% | 20.78% |
| Annualized return | 98.36% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | TEVA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 288.69% | 83.14% |
| Annualized return | 31.20% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | TEVA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -25.27% | 319.30% |
| Annualized return | -2.87% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.